Massachusetts Financial Services’s BeOne Medicines Ltd ONC Stock Holding History

Massachusetts Financial Services’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18M	Buy	8,175 +360	+5%	+$106K	0.01%	686
2026 Q1	$17.9M	Buy	7,815 +320	+4%	+$104K	0.01%	658
2025 Q4	$2.28M	Buy	7,495 +400	+6%	+$131K	﹤0.01%	779
2025 Q3	$2.42M	Sell	7,095 -1,519	-18%	-$461K	﹤0.01%	750
2025 Q2	$2.09M	Sell	8,614 -7,005	-45%	-$1.72M	﹤0.01%	763
2025 Q1	$4.25M	Sell	15,619 -12,304	-44%	-$2.88M	﹤0.01%	709
2024 Q4	$5.16M	Buy	27,923 +16,049	+135%	+$3.28M	﹤0.01%	692
2024 Q3	$2.67M	Buy	+11,874	New	+$2.14M	﹤0.01%	707

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Massachusetts Financial Services's ONC Position: Q2 2026 in Review

Massachusetts Financial Services increased its BeOne Medicines Ltd (ONC) stake by 4.6% in Q2 2026, buying an estimated $106K and bringing the position to 8,175 shares worth $18M. The position accounts for 0.01% of the portfolio, ranked #686.

Massachusetts Financial Services first reported a position in ONC in Q3 2024 and has held it in 8 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Massachusetts Financial Services held 8,175 shares of BeOne Medicines Ltd worth $18M as of Q2 2026.
Massachusetts Financial Services bought 360 BeOne Medicines Ltd shares in Q2 2026, an estimated $106K.
BeOne Medicines Ltd made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #686 holding.
Massachusetts Financial Services first reported a position in BeOne Medicines Ltd in Q3 2024 and has held it in 8 quarters since.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.